It-Chem아이티켐
309710 · KOSDAQ · ₩309710 · 아이티켐
- Market cap
- ₩268B
- Enterprise value
- ₩330B
- P/E
- —
- P/B
- 4.5×
- Dividend yield
- 0.0%
- ROE
- −29.6%
- Net margin
- −33.4%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−62.0% from the high
₩20,150Today: ₩21,000 – ₩21,000₩55,200
Returns
- 1W0.0%
- 1M0.0%
- 3M0.0%
- 6M0.0%
- YTD−39.4%
- 1Y−34.7%
- Volume today
- —
- Traded today
- —
- Listed shares
- 12,783,001
- EPS (12 months)
- −₩1,387
- Earnings yield −6.6%
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Normal- BuzzNormalBuzz 47 of 100 (50 is a normal day for this stock).
- MomentumFlat0% over the last month; the price is below its 20-day average.
Signals describe activity, not recommendations. Not financial advice.
It-Chem stock overview
It-Chem (아이티켐, KRX: 309710) is listed on KOSDAQ, in the Biotech & Pharma sector. The company is a Korean specialty chemical firm that develops and mass-produces fine chemical products through synthesis technology, mainly active pharmaceutical ingredients and intermediates for global pharmaceutical customers and OLED display materials for global display panel makers. Its shares closed at ₩21,000 on Oct 28, 2026, unchanged on the day, giving it a market value of ₩268B.
Key facts
- Market cap
- ₩268B
- Sector
- Biotech & Pharma
- Latest price change
- 0.00%
- As of
- Oct 28, 2026
- Main business
- The company is a Korean specialty chemical firm that develops and mass-produces fine chemical products through synthesis technology, mainly active pharmaceutical ingredients and intermediates for global pharmaceutical customers and OLED display materials for global display panel makers.
Quick answers about It-Chem
- What does It-Chem do?
- The company is a Korean specialty chemical firm that develops and mass-produces fine chemical products through synthesis technology, mainly active pharmaceutical ingredients and intermediates for global pharmaceutical customers and OLED display materials for global display panel makers. It also supplies OPC drum materials for printer cartridges, mainly to Chinese customers, and is developing oligopeptide, oligonucleotide, and heavy water (D2O) businesses. Its operations are based in Korea, where it has a heavy water recycling facility in Goesan.
- What is the market cap of It-Chem?
- The market capitalisation of It-Chem was ₩268B at the close on Oct 28, 2026.
- Who are the largest shareholders of It-Chem?
- According to the latest official filings, the largest reported holders are Q Investment (41.53%, as of Aug 14, 2025); Ocular No.1 Private Equity Fund (20.93%, as of Mar 18, 2026); Paratus Innovation Growth M&A Private Equity Fund (2.72%, as of Aug 14, 2025).
- When is the next earnings report from It-Chem?
- Korean companies rarely announce results dates in advance. Based on when It-Chem filed the same report in past years, its next 3q results is expected around Nov 28, 2026.
Company profile
The company is a Korean specialty chemical firm that develops and mass-produces fine chemical products through synthesis technology, mainly active pharmaceutical ingredients and intermediates for global pharmaceutical customers and OLED display materials for global display panel makers. It also supplies OPC drum materials for printer cartridges, mainly to Chinese customers, and is developing oligopeptide, oligonucleotide, and heavy water (D2O) businesses. Its operations are based in Korea, where it has a heavy water recycling facility in Goesan.
Written by AI from the company's latest annual report.
- Korean name
- 아이티켐
- Sector
- Biotech & Pharma
- Themes
- —
- CEO
- 김인규
- Founded
- May 2005
- Listed
- Aug 2025
- Listed shares
- 12,783,001
- Fiscal year ends
- Month 12
- Website
- itchem.co.kr/home/main.php
Similar companies
- Samsung Biologics207940 · ₩64T₩1,372,000−0.15%
- Celltrion068270 · ₩44T₩189,800+0.64%
- Alteogen196170 · ₩16T₩223,000+2.06%
- SK biopharmaceuticals326030 · ₩5.9T₩75,200+0.40%
- Yuhan000100 · ₩5.7T₩77,300−3.38%
- HLB028300 · ₩5.4T₩40,650+1.88%
- Hanmi Pharm128940 · ₩4.7T₩369,500+5.42%
- SAM Chun Dang Pharm000250 · ₩4.5T₩190,000+1.28%
Recent filings
See all- Adjustment of Conversion Price (1st Series)Sep 28, 2026
- Confirmation of Facts Such as Adverse Opinion on Semi-annual Review (Audit), Including Capital Impairment Ratio of 50% or More or Equity Under ₩1BAug 28, 2026
- Added attachment: Half-year report (Jun 2026)Aug 28, 2026
- Quarterly report (Mar 2026)Jun 1, 2026
- Trading haltApr 24, 2026
Titles in Korean until English translations are added.
Also known as: It-Chem / 아이티켐 / 309710 / KRX:309710
Source: KRX statistical information